UNRESECTABLE CUTANEOUS MELANOMA
Clinical trials for UNRESECTABLE CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Gut-Focused drug revive immunotherapy for tough melanomas?
Disease control Not yet recruitingThis study tests whether adding axelopran, a drug that blocks opioid side effects in the gut, to the immunotherapy nivolumab can help people with advanced melanoma that no longer responds to PD-1 inhibitors. The trial includes about 28 adults with unresectable or metastatic cutan…
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: John Kirkwood • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a smaller dose of this cancer drug still work? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial is testing whether a lower dose of the immunotherapy drug nivolumab, given less often, can still control cancer in people with various advanced or metastatic cancers. The goal is to see if a cheaper, more accessible regimen works as well as the standard high-co…
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC